Skip to main content

Morphine Sulfate Extended-Release Tablets Shortage

Last Updated: May 11, 2025
Status: Current

Products Affected - Description
    • MS Contin oral extended release tablet, Rhodes, 100 mg, bottle, 100 count, NDC 42858-0799-01 - discontinued
    • MS Contin oral extended release tablet, Rhodes, 200 mg, bottle, 100 count, NDC 42858-0900-01 - discontinued
    • Morphine sulfate oral extended release tablet, Major, 15 mg, unit-dose blister pack, 100 count, NDC 00904-6557-61
    • Morphine sulfate oral extended release tablet, Major, 60 mg, unit-dose blister pack, 100 count, NDC 00904-6559-61
    • Morphine sulfate oral extended release tablet, Teva, 100 mg, bottle, 100 count, NDC 00228-4323-11
    • Morphine sulfate oral extended release tablet, Teva, 15 mg, bottle, 100 count, NDC 00228-4270-11
    • Morphine sulfate oral extended release tablet, Teva, 30 mg, bottle, 100 count, NDC 00228-4271-11
    • Morphine sulfate oral extended release tablet, Teva, 60 mg, bottle, 100 count, NDC 00228-4311-11
Reason for the Shortage
    • Major did not provide a reason for the shortage.
    • Mallinckrodt refuses to provide availability information.
    • Rhodes has morphine sulfate extended-release tablets available. Rhodes discontinued MS Contin 100 mg and 200 mg tablets.
    • Sun has morphine sulfate extended-release tablets available.
    • Teva did not provide a reason for the shortage.
Available Products
    • MS Contin oral extended release tablet, Rhodes, 15 mg, bottle, 100 count, NDC 42858-0515-01
    • MS Contin oral extended release tablet, Rhodes, 30 mg, bottle, 100 count, NDC 42858-0631-01
    • MS Contin oral extended release tablet, Rhodes, 60 mg, bottle, 100 count, NDC 42858-0760-01
    • Morphine sulfate oral extended release tablet, Major, 100 mg, unit-dose blister pack, 100 count, NDC 00904-6560-61
    • Morphine sulfate oral extended release tablet, Major, 30 mg, unit-dose blister pack, 100 count, NDC 00904-6558-61
    • Morphine sulfate oral extended release tablet, Rhodes, 100 mg, bottle, 100 count, NDC 42858-0804-01
    • Morphine sulfate oral extended release tablet, Rhodes, 15 mg, bottle, 100 count, NDC 42858-0801-01
    • Morphine sulfate oral extended release tablet, Rhodes, 200 mg, bottle, 100 count, NDC 42858-0805-01
    • Morphine sulfate oral extended release tablet, Rhodes, 30 mg, bottle, 100 count, NDC 42858-0802-01
    • Morphine sulfate oral extended release tablet, Rhodes, 60 mg, bottle, 100 count, NDC 42858-0803-01
    • Morphine sulfate oral extended release tablet, Sun Pharma, 100 mg, bottle, 100 count, NDC 63304-0452-01
    • Morphine sulfate oral extended release tablet, Sun Pharma, 15 mg, bottle, 100 count, NDC 63304-0450-01
    • Morphine sulfate oral extended release tablet, Sun Pharma, 200 mg, bottle, 100 count, NDC 63304-0453-01
    • Morphine sulfate oral extended release tablet, Sun Pharma, 30 mg, bottle, 100 count, NDC 63304-0451-01
    • Morphine sulfate oral extended release tablet, Sun Pharma, 60 mg, bottle, 100 count, NDC 63304-0758-01
    • Morphine sulfate oral extended release tablet, Teva, 200 mg, bottle, 100 count, NDC 00228-4347-11

Estimated Resupply Dates

    • Major has morphine sulfate 15 mg and 60 mg extended-release tablets in 100 count unit-dose packages on back order and the company estimates a release date of early-June2025.
    • Teva has morphine sulfate 15 mg, 30 mg, 60 mg, and 100 mg extended-release tablets in 100 count bottles on back order and the company cannot estimate a release date for the 15 mg and 100 mg products. The company estimates a release date of mid-May 2025 for the 30 mg and 60 mg products.

Updated

Updated May 11, 2025 by Elyse MacDonald, PharmD, MS, BCPS. Created December 12, 2024 by Leslie Jensen, PharmD, Drug Information Specialist. © 2025, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer